|
||
© The Rockefeller University Press,
0021-9525/2000//665 $5.00
The Journal of Cell Biology, Volume 148, Number 4,
, 2000 665-678
Original Article |
Gelsolin Deficiency Blocks Podosome Assembly and Produces Increased Bone Mass and Strength
khruska{at}imgate.wustl.edu
Osteoclasts are unique cells that utilize podosomes instead of focal adhesions for matrix attachment and cytoskeletal remodeling during motility. We have shown that osteopontin (OP) binding to the
vβ3 integrin of osteoclast podosomes stimulated cytoskeletal reorganization and bone resorption by activating a heteromultimeric signaling complex that includes gelsolin, pp60c-src, and phosphatidylinositol 3'-kinase. Here we demonstrate that gelsolin deficiency blocks podosome assembly and
vβ3-stimulated signaling related to motility in gelsolin-null mice. Gelsolin-deficient osteoclasts were hypomotile due to retarded remodeling of the actin cytoskeleton. They failed to respond to the autocrine factor, OP, with stimulation of motility and bone resorption. Gelsolin deficiency was associated with normal skeletal development and endochondral bone growth. However, gelsolin-null mice had mildly abnormal epiphyseal structure, retained cartilage proteoglycans in metaphyseal trabeculae, and increased trabecular thickness. With age, the gelsolin-deficient mice expressed increased trabecular and cortical bone thickness producing mechanically stronger bones. These observations demonstrate the critical role of gelsolin in podosome assembly, rapid cell movements, and signal transduction through the
vβ3 integrin.
Key Words: gelsolin phosphatidylinositol 3'-kinase actin podosomes osteoclasts
© 2000 The Rockefeller University Press
| Introduction |
|---|
|
|
|---|
-actinin (Marchisio et al. 1984). The presence of gelsolin in osteoclast podosomes is known but its function is not (Zambonin-Zallone et al. 1983, Zambonin-Zallone et al. 1989; Marchisio et al. 1984, Marchisio et al. 1987; Lakkakorpi and Vaananen 1991). Gelsolin, an actin-binding protein, controls the length of actin filaments in vitro, and cell shape and motility in vivo by a variety of mechanisms (Cunningham et al. 1991). Gelsolin severs assembled actin filaments, caps the fast-growing plus ends, and promotes growth of actin filament by creating nucleation sites (Stossel 1989). Severing and capping are regulated by calcium ions and pH, which synergistically activate gelsolin's binding to actin. Binding of gelsolin to phosphoinositides causes the release of gelsolin from the filament end (uncapping), providing a site for rapid monomer addition (Janmey and Stossel 1987; Janmey et al. 1987).
In avian osteoclasts, we have shown previously that osteopontin (OP) binding to integrin
vβ3 in osteoclasts stimulates gelsolin-associated PI3-K, leading to increased levels of gelsolin-associated polyphosphoinositides such as phosphatidylinositol 4,5-bisphosphate, phosphatidylinositol 3,4-bisphosphate, phosphatidylinositol 3,4,5,-trisphosphate, uncapping of actin barbed ends, and actin filament formation. Inhibition of PI3-K blocks OP-stimulated actin filament formation, and cell motility (Chellaiah and Hruska 1996). Recently, we have demonstrated that OP stimulation of gelsolin-associated pp60c-src is upstream of PI3-K. Antisense oligonucleotides to pp60c-src blocked OP stimulation of gelsolin-associated PI3-K as well as the downstream effects on the cytoskeleton and bone resorption (Chellaiah et al. 1998).
Gelsolin-deficient (Gsn–/–) mice, generated by gene targeting methods (Witke et al. 1995), express mild physiological dysfunction during hemostasis, inflammation, and possibly skin remodeling, but gelsolin was not required for oocyte development, spermatogenesis, embryonal development, or longevity. Gsn–/– dermal fibroblasts have excessive actin stress fibers and migrate more slowly than wild-type (Gsn+/+) fibroblasts, but have increased contractility in vitro (Witke et al. 1995). The skeleton of Gsn–/– mice has not been formally analyzed, but tooth eruption and bone development appear normal. Bone cells from Gsn–/– mice have not been studied.
We show here that elimination of gelsolin resulted in osteoclasts devoid of podosomes and actin rings. Mechanisms of cell attachment substituting for podosomes were expressed, but these failed to support cell motility. However, they were sufficient to enable cell polarization and bone resorption. Gsn–/– osteoclasts failed to respond to OP with stimulation of motility and bone resorption. Endochondral bone formation was abnormal with delayed resorption of calcified cartilage and thicker metaphyseal trabeculae. Adult Gsn–/– mice developed thicker cortical and trabecular bone, which was more resistant to fracture, compatible with a mild imbalance between bone resorption and formation.
| Materials and Methods |
|---|
|
|
|---|
Coculture and Generation of Murine Osteoclasts In Vitro
Mouse osteoclasts were generated in vitro using the mouse bone marrow and stromal cell coculture system essentially as described (Shioi et al. 1994). After coculture for 6–9 d, ST2 cells were removed by treatment with collagenase and dispase (1 mg/ml each in PBS) at 37°C for 20 min as described (Wesolowski et al. 1995). After washing the cultures with PBS, all of the ST2 cells (99%) were removed. The remaining attached cells were rinsed with PBS, and the cultures were kept in cell dissociation buffer for an additional 5 min. Cells were removed from the plates by gentle scraping. Some of the removed cells were replated and stained with either trypan blue or for tartrate-resistant acid phosphatase (TRAP). Cells excluded trypan blue, and they were 99% TRAP-positive. These TRAP-positive cells were used for migration and bone resorption assays as described below.
Actin Staining
The mouse osteoclasts generated in cocultures were placed in 6-well clusters containing glass coverslips. Osteoclasts attached to the plates and were treated with OP (25 µg/ml) or vehicle as described previously (Chellaiah and Hruska 1996). Actin staining was carried out as described previously (Chellaiah et al. 1998).
Measurement of F-Actin Content Using Rhodamine-Phalloidin Binding
Osteoclasts were made as described above. After coculture for 6–9 d, ST2 cells were removed by treatment with collagenase and dispase (1 mg/ml each in PBS) at 37°C for 20 min as described (Wesolowski et al. 1995). Plates were washed two to three times with serum-free
-MEM medium and the remaining attached cells were kept in serum-free
-MEM medium for 2 h. Cells were treated with PBS or OP for 15 min. For each treatment four to six wells were used. The cells were fixed and rhodamine-phalloidin binding to F-actin was done as described (Chellaiah and Hruska 1996; Chellaiah et al. 1998).
Cell Migration Assays
Phagokinesis.
Substrates such as recombinant chicken OP, vitronectin, or fibronectin were diluted in PBS and used for phagokinesis assays, which were performed in 6-well tissue culture dishes. Colloidal gold particles were made essentially as described (Takahashi et al. 1995). Osteoclasts isolated (see above) were seeded at low density (103 cells/well). Once the cells were attached to the wells, the substrates were added as soluble protein (OP, 25 µg/ml; vitronectin or fibronectin, 10 µg/ml) in
-MEM containing 1% serum and 2% BSA. Some wells were treated with an antibody to OP (50 µg/ml) and OP (25 µg/ml). The cells migrated on this substrate, and phagocytized the gold particle to produce a white track free of the particle in a time-dependent manner. The migrating cells were visible as a black body (Takahashi et al. 1995). Areas were measured after 14-h incubations with the proteins. Cell motility was evaluated by measuring the areas free of gold particles. By using a grided reticule (Boyce Scientific, Inc.) in the eyepiece of a Nikon microscope, areas free of gold particles were measured using a 10x objective. Areas free of gold particles were represented as area moved in mm2.
Haptotaxis (Transwell Migration) Assay.
To assay cell migration, Transwell migration chambers (8-µm pore size) were used (Senger et al. 1996). Undersides of the membranes were coated with vitrogen 100 (collagen type 1; 30 mg/ml) at room temperature for 2 h according to the manufacturer's instructions. Osteoclasts isolated as described above were pelleted and resuspended in
-MEM medium containing 1% serum and 2% BSA (50,000 cells/ml). Cells were added to the upper chamber in the above mentioned medium (100 µl) and substrates like OP (25 µg/ml) or vitronectin or fibronectin (10 µg/ml) were added to the lower chamber in
-MEM medium containing 1% serum and 2% BSA (600 µl). Cell migration was allowed to proceed at 37°C in a standard tissue culture incubator for 12–14 h. Cells that migrated to the undersides were stained, visualized, and counted as described (Senger et al. 1996). Data are presented as the number of migrated cells field (mean ± SEM) and all assays were performed in quadruplicate. Statistical significance was calculated as mentioned below in data analysis.
Bone Resorption Assay
Whale dentine slices (1.5 cm2 in size and 0.75 mm in thickness) were cut from previously prepared rectangular sticks on a low-speed saw and were stored in 70% ethanol until required. Before being used in a resorption assay, the slices were sonicated for 3–5 min in distilled water and washed for 2 h in two changes of fresh distilled water. The slices were resterilized in fresh 70% ethanol and placed into wells of a 48-well tissue culture plate. After three washes with
-MEM serum-free media, the slices were placed overnight in a 37°C incubator in the same media. The osteoclast suspension (2 x 104 cells) was added to each well, and after 2 h of adherence the culture media were replaced with
-MEM containing either vehicle (PBS) or 25 µg/ml mouse OP expressed in bacteria. After incubation for 48 h, cells were scraped from the slices and the slices were washed 7–10 times with water. Pits were stained with acid hematoxylin (Sigma Chemical Co.) for 6 min, washed well with water, and counted. The number of pits was determined microscopically. The effect of test substances on bone resorption was determined by scanning the pit areas and pit depth as described below.
Measurement of Pit Area and Depth
Photomicrographs were obtained with the Zeiss LSM 410 scanning laser confocal microscope system, which employs a Zeiss 135 Axiovert inverted microscope fitted with an Omnicron Argon/Krypton laser for confocal excitation. The dentine slices mounted on No. 1 coverslips were viewed with a 40 x 0.6 NA air objective. Images were recorded in the epi-reflection mode using the 488-nm line of the argon laser in a 512 x 512 pixel format. Data collection and processing were accomplished with the Zeiss LSM 410 software package. Photomicrographs were produced from a Sony Mariograph color video printer or stored in a TIFF image format for post collection image processing. An XY digital image of each pit was first obtained. The area of the pit was determined from the free-hand traced perimeter using the LSM software Area Measurement function. The depth profile of the pit was obtained using the LSM Z Scan function to form an XZ profile. The maximum pit depth was determined from this scan using the LSM software Distance Measurement function. All depth measurements were corrected for the presence or absence of immersion oil.
Immunostaining
Osteoclasts cultured on whale dentine slices or glass coverslips were immunostained with an antibody (E11; kindly provided by Dr. Stephen Gluck, University of Florida College of Medicine, Gainesville, FL) to 31-kD subunit of vacuolar H+ ATPase (Hemken et al. 1992) or gelsolin antibody as described (Wu et al. 1991; Chellaiah et al. 1996). In brief, cells were fixed with 3% paraformaldehyde and permeabilized with 10 mM Tris-HCl, pH 7.4, 150 mM NaCl, and 1 mM CaCl2 containing 0.1% Triton X-100 for 1 min. The cells were washed and incubated with E11 antibody or gelsolin antibody (1:100 dilution) for 2 h, washed, and counter stained with Cy2-conjugated goat anti–mouse IgG for 2 h. The cells were washed and mounted on a slide in a mounting solution (Vector Laboratories, Inc.). The cells were viewed on a Zeiss LSM 410 confocal laser scanning microscope and photomicrographs were obtained as described (Gupta et al. 1996). Images were recorded as described below.
Lysate Preparation and Western Analysis
After ST2 cells were removed as described above in osteoclast preparation, cells were washed three times with ice-cold PBS and lysates were made from osteoclasts derived from Gsn–/– and Gsn+/+ mice as described previously (Chellaiah and Hruska 1996). Protein contents were measured using the Bio-Rad protein assay reagent kit. Equal amounts of lysate proteins were immunoprecipitated with an antibody to gelsolin (Sigma Chemical Co.) or nonimmune serum. Immunoprecipitations and Western analysis were carried out as described (Chellaiah and Hruska 1996).
Immune Complex Kinase Assay Analysis for src and PI3-K
Equal amounts of protein lysates made from PBS or OP-treated cells were immunoprecipitated with an antibody to gelsolin. The immunecomplexes, adsorbed to protein A–Sepharose pellets, were assayed for pp60-src or lipid kinase (PI3-K) activity as described previously (Chellaiah and Hruska 1996; Chellaiah et al. 1998).
Polarization of the H+ ATPase in Gsn–/– Osteoclasts
Images were collected on the Zeiss laser scanning confocal system in the dual imaging mode. One detector was set to image in FITC fluorescence (488 nm laser line excitation, 515–540 nm FITC emission), and the second detector was set to record the backscattered epi-reflection image using the 568-nm laser line. The two images were collected simultaneously. The green FITC fluorescence image was stored in the green frame, and the 568-nm epi-reflection image was stored in the red frame. The composite color image was viewed as green fluorescence plus red epi-reflection.
Bone Histomorphometry
The distal tibia were fixed in phosphate-buffered 10% formalin, pH 7.4, and decalcified in 14% EDTA for 10–14 d. The bones were washed sequentially with 50, 70, and 90% ethanol and embedded. 5-µm thick longitudinal sections were made and stained with toluidine blue stain or TRAP staining to identify osteoclasts. To estimate mineral opposition rate and bone formation rate, mice were injected with calcein at 2 and 5 d before sacrificing. The distal right femur was kept in 90% ethanol and embedded. Longitudinal sections were made. Static and dynamic histomorphometric measurements were made using a computer and digitizer tablet (Osteomeasure; Osteometrics Inc.) interfaced to a Leitz microscope (Leitz Wetzlar) with a drawing tablet. All measurements were done to the metaphyseal region distal to the growth plate region. To estimate bone formation rate, double labeled and single labeled areas were traced and calculated as described (Jilka et al. 1996; Weinstein et al. 1997). Terminology used is that recommended by the Histomorphometry Nomenclature Committee of the American Society of Bone and Mineral Research (Parfitt et al. 1987).
Mechanical Properties of the Femora from Gsn+/+ and Gsn–/– Mice
The left femora from 16 mice was designated for biomechanical testing. Femora were isolated, cleaned of soft tissues, wrapped in gauze that was soaked with PBS, wrapped again in plastic, placed in a sealed vial, and stored at –20°C until testing. Before testing, specimens were thawed to 23°C. Four-point bending tests were conducted using a materials testing machine (8500R; Instron) fitted with an appropriate load transducer (111 N force cell; Lebow 3397). Tests were conducted using a four-point fixture with a 9-mm spacing between the outer (support) points and a 4-mm spacing between the inner (loading) points. The bones were flexed in the anterior-posterior plane (Jepsen et al. 1996). The inner points were displaced at a constant rate of 0.03 mm/s. Torque rotation and force displacement data were collected using a computerized data acquisition system (Labview 5.0; National Instruments).
After testing, force values (F) from the bending tests were converted to bending moment values (M) using the relation M = Fa/2, where a was the distance between the outer and inner points (2.5 mm). Displacement data were normalized by a geometric factor to allow direct comparison between other experiments done using different testing geometries. Displacement values were divided by (3aL – 4a2)/6, where L is the distance between the outer points. From the moment versus normalized displacement curves, four parameters were computed: ultimate moment (Nmm), bending rigidity (Nmm2), displacement at failure (mm/mm2), and energy to failure (Nmmx[mm/mm2]). Failure was defined at the point of ultimate (maximum) moment, whereas bending rigidity was defined as the slope of the linear region of the curve.
Data Analysis
All comparisons were made as "% control", which refers to vehicle-treated cells. The other treatment groups in each experiment were normalized to each control value. Data presented are mean ± SEM of experiments done at different times normalized to intraexperimental control values. For statistical comparisons, analysis of variance (ANOVA) was used with the Bonferroni corrections (Instat for IBM, version 2.0; Graphpad software).
| Results |
|---|
|
|
|---|
|
|
Analysis of Expression of Gelsolin in Osteoclasts
Gelsolin is an actin capping protein of podosomes (Zambonin-Zallone et al. 1983, Zambonin-Zallone et al. 1989; Marchisio et al. 1984, Marchisio et al. 1987). Immunostaining of osteoclasts derived from cells of wild-type mice with antigelsolin antibody showed that gelsolin was strongly colocalized with actin in podosomes (Fig. 3 A, Gsn+/+) and colocalized along the inner edge of actin ring–like structures (Fig. 3 A, Gsn+/+). Immunostaining of osteoclasts isolated from Gsn–/– mice documented the absence of gelsolin expression in the Gsn–/– mice (Fig. 3 A, Gsn–/–). The few green spots observed in the Gsn–/– mice are either nonspecific or bleed through from the red channel. In addition, Western analysis of the antigelsolin immunoprecipitates made from the lysates of Gsn–/– osteoclasts demonstrates the absence of gelsolin (Fig. 3 B, lane 2).
|
-actinin, profilin, or CapG had no effect on actin filament formation (Chellaiah and Hruska 1996).
|
vβ3 stimulated association signal generating molecules with gelsolin in avian osteoclasts (Chellaiah and Hruska 1996; Chellaiah et al. 1998). To see whether OP stimulation in mouse osteoclasts produced similar activation as seen in avian osteoclasts, in vitro kinase assays were performed on the immune complexes generated by using a gelsolin antibody. In vitro immune complex kinase assays for pp60c-src have demonstrated that OP induced an increase in phosphorylation of pp60c-src (Fig. 5A and Fig. B) and increased its activity towards phosphorylating an exogenous substrate, casein (Fig. 5 B). In addition, phosphorylation of two other proteins with the molecular masses of 125 kD (Fig. 5A and Fig. B) and 85 kD (Fig. 5 B) was observed. p85 protein was identified as PI3-K in avian osteoclasts (Chellaiah and Hruska 1996). Coimmunoprecipitation of PI3-K with gelsolin was further confirmed by a PI3-K assay (Fig. 5 C). OP stimulation of PI3-K activity associated with gelsolin is evident from the phosphorylation of the exogenous substrate, phosphatidylinositol 4,5-bisphosphate to phosphatidylinositol 3,4,5-trisphosphate (Fig. 5 C).
|
vβ3 integrin (data not shown), which were dramatically redistributed at 15 min. Vinculin was detected in the newly formed podosomes of the OP-treated Gsn+/+ osteoclasts, probably translocating from an intracellular pool different from the formed adhesion structures. In Gsn–/– osteoclasts, vinculin was also arrayed peripherally in discrete attachment sites with a unique structure not resembling podosomes or focal adhesions (Fig. 6, middle panels). In Gsn–/– osteoclasts with a diffuse actin distribution as in Fig. 1, vinculin was also arrayed diffusely with discrete attachment sites scattered throughout the cells (Fig. 6, lower panels).
|
|
|
|
|
|
|
Assessment of the Mechanical Strength of Bones
The imbalance between bone resorption and formation and the increased mineralization reported here may have affected bone strength, and the ability of the skeleton to resist damage (fracture) may be altered. To test this possibility, we performed four-point bending tests of mouse bones to assess their mechanical strength, as described in Materials and Methods. As shown in Fig. 11 and Table , the Gsn–/– bones required greater energy and greater maximal displacement to produce femoral failure compared with the Gsn+/+ femurs. Changes in bone stiffness resulting from over mineralization and decreased remodeling seen in some osteopetroses were not observed in the bones from the Gsn–/– mice.
|
|
| Discussion |
|---|
|
|
|---|
Gelsolin is the prototype of a large family of proteins that sever actin filaments, nucleate actin filament assembly, and block the fast exchanging end of actin filaments (Stossel 1989). Therefore, the opportunity for redundancy of function in actin dynamics is high (Yin 1987, Yin 1989; Vandekerckhove and Vancompernolle 1992; Weeds and Maciver 1993; Schafer and Cooper 1995) and the redundancy of actin-regulating proteins is manifested by the Gsn–/– mouse. Since gelsolin is not expressed during development, cell motility in support of development should be normal, and transgenic mice lacking gelsolin expression exhibit normal motility of embryonic fibroblasts (Witke et al. 1995). However, dermal fibroblasts from adult Gsn–/– mice have increased actin stress fiber size, decreased actin severing, and hypomotility. In addition, resting platelets isolated from Gsn–/– mice have an increased F-actin content, and they are slow to remodel their actin cytoskeleton when activated (Barkalow and Hartwig 1995). According to the model of regulated treadmilling for regulation of actin dynamics through the filament-nucleating activity of the Arp 2/3 complex (Machesky and Insall 1999), the findings in gelsolin deficiency are compatible with capping protein serving to complement for gelsolin deficiency with the only outcome being reduction in the rates of motility (Andre et al. 1989; Witke et al. 1995). Thus, our findings that gelsolin is required for podosome assembly is surprising. They establish that the podosome is a unique cell attachment structure, and that in its case, gelsolin capping of actin filaments cannot be substituted. The data also raise the question as to whether podosome assembly utilizes regulated treadmilling and the Arp 2/3 complex for actin filament elongation or whether gelsolin uncapping barbed ends is sufficient for this purpose.
Gsn–/– osteoclasts were adherent through novel cell–matrix interaction sites, e.g., vinculin-containing focal contacts distinct from focal adhesions, and they were able to polarize their actin cytoskeleton and plasma membranes sufficiently to enable bone resorption. These redundant mechanisms of actin regulation were sufficient for basal rates of bone resorption measured on dentine slices in vitro. However, Gsn–/– osteoclasts had a major decrease in motility in vitro, demonstrating that the redundant cell–matrix attachment mechanisms were unable to support the rates of assembly and disassembly observed in podosomes that enable high motility rates. This may be the critical component of the osteoclast phenotype in vivo, since the histomorphometric findings demonstrated that bone resorption measured by eroded perimeters was diminished. The findings of hypomotility in vitro and reduced bone resorption in vivo are compatible with the physiologic character of bone resorbing osteoclasts that display high motility rates. Therefore, our data suggest that motility is an important component of bone resorption.
Whereas hypomotility of leukocytes and fibroblasts was a central focus of the reported phenotype of Gsn–/– mice (Witke et al. 1995), these cells are motile through the process of cellular extensions, filopodia and lamellipodia, establishing new contacts, and pulling the trailing edge of the cell (Lauffenburger and Horwitz 1996). Gelsolin has been shown to be an obligate downstream effector of rac-stimulated fibroblast motility (Azuma et al. 1998), where its severing of cortical actin is required for membrane ruffling, and the loss of gelsolin severing may have produced the decrease in motility. In the studies reported here related to the absence of podosome assembly, the basis for the defect appears related to gelsolin-capping function that must be required in order for the podosome structure to be completed. Several studies have shown a relationship between gelsolin content and cell migration (Chaponnier et al. 1990; Cunningham et al. 1991; Arora and McCulloch 1996; Kwiatkowski 1999). Increasing gelsolin content in cultured fibroblasts by transfection proportionally enhances the rate of cell migration toward a chemoattractant (Cunningham et al. 1991; Arora and McCulloch 1996). Large increases in gelsolin content are also associated with the enhanced motility exhibited during differentiation of myeloid cell lines into macrophage-like cells (Kwiatkowski 1988). However, it has been shown that high gelsolin content is associated with reduced cell migration and increased adhesion in smooth muscle and mammary carcinoma cells (Chaponnier and Gabbiani 1989; Chaponnier et al. 1990). Thus, the capping or severing functions of gelsolin may be variably important depending upon the cell type, but only in the case of podosome assembly is gelsolin critical.
Osteoclasts are unique in that their mechanism of cell motility is podosome based. They do not express focal adhesions, and they use the speed of podosome assembly and disassembly to generate high rates of motility. Gelsolin is present in podosomes of osteoclasts but not in focal adhesions (Marchisio et al. 1987). The greater reliance on podosomes for cell attachment in osteoclasts called immediate attention to podosome absence in Gsn–/– osteoclasts. Even the actin ring structure of the bone resorbing osteoclast is a coalescence of dense rows of podosomes, and they were absent in Gsn–/– osteoclasts. Osteoclasts are uniquely motile in that they continue to resorb bone beneath one area of the cell undersurface while another area is reorganizing and moving (Taylor et al. 1989). The result is the production of complex resorption pits with a serpentine character (Taylor et al. 1989). The rapidity of podosome assembly and disassembly enables this feature of coordinating cell function with motility (Kanehisa and Heersche 1988; Kanehisa et al. 1990), another property shared between metastatic cancer cells and osteoclasts. Thus, as reported herein, impaired motility of Gsn–/– osteoclasts is associated with diminished rates of bone resorption.
Gelsolin plays a key role in integrin-based signaling through podosomes as it is organized in a signaling complex containing PI3-K, pp60c-src, and other signaling molecules (Chellaiah and Hruska 1996; Chellaiah et al. 1998). As shown here, this complex is expressed in murine wild-type osteoclasts, and the role of this complex is demonstrated by the absence of response to OP in the Gsn–/– osteoclasts. The receptor for OP signaling is the
vβ3 integrin (Chellaiah and Hruska 1996; Chellaiah et al. 1998), also localized to the osteoclast podosome (Zambonin-Zallone et al. 1989). In the Gsn–/– osteoclasts,
vβ3 was expressed in the unique focal contacts, and OP was secreted into the resorption space (Chellaiah, M., unpublished observations). Thus, the major deficiency in the response to OP was the organization of signaling around gelsolin in the podosome for motility. The Gsn–/– osteoclasts organized their cytoskeleton and polarized sufficiently to resorb bone. Thus, signal transduction through
vβ3 and the focal contacts that substitute for podosomes may explain the basal rates of bone resorption in vitro, and osteoclast function sufficient to support development of the skeleton and normal rates of endochondral bone growth in vivo.
Histomorphometric analysis of bones from Gsn–/– mice documented reduced resorption of calcified cartilage in the epiphyses of the long bones. The epiphyses were mildly disorganized with increased cartilage matrix. The metaphyseal bone trabeculae were thicker than those observed in Gsn+/+ bones, and they had retained cartilage proteoglycans. Cancellous bone area was increased, and the eroded surface area was decreased. Both trabecular and cortical bone were thicker, and the cause of this appeared to be decreased osteoclast function in the presence of normal osteoblast function. Osteoblast number and surfaces were normal, as were bone formation rates, which tended to be elevated although not significantly. The deficiency in osteoclast function was not sufficient to affect endochondral bone growth, and the shortening and clubbing of the femurs reported in some osteopetrotic states was not observed (Marks 1989; Hayman et al. 1996). The effect of thicker trabeculae and cortices on bone strength was an increase in load required to produce failure, and an increase in the ultimate normalized displacement to produce fracture.
Skeletal diseases characterized by sclerosis resulting from reduced osteoclast-mediated bone resorption are referred to as the osteopetroses (Marks 1989). Osteopetrosis is a heterogeneous group of disorders that range in severity from lethal to the very mild disorder reported here. The lethal disorders result from an absence of marrow cavity formation and the limited development of hematopoiesis. The milder disorders are associated with shortening and deformity of the long bones and axial skeleton, but tooth eruption, hearing, and skull plate development (Hayman et al. 1996). The osteopetrosis reported here is even milder in that endochondral bone lengths were normal. The milder forms of osteopetrosis have been associated with significant effects on skeletal mineralization demonstrating progressive increases in bone density as observed here by the increase in mineral apposition rate (Hayman et al. 1996).
An effect of osteoclast dysfunction on mineralization was suggested in the Acp5 TRAP-deficient homozygous mutant mice. TRAP may dephosphorylate OP in the osteoclast resorption space (Ek-Rylander et al. 1994), and as a result increase mineralization by affecting the role of OP in the bone formation that follows cessation of osteoclast function.
Thus, the findings reported here of thickened calcified cartilage trabeculae, delayed cartilage resorption, and diminished eroded perimeters demonstrate a mild osteopetrosis that was not developmentally important nor sufficient to affect growth, but it was sufficient to increase trabecular and cortical bone thickness with age resulting in increased skeletal strength. The findings reported here resemble the long-term outcome of aminobisphosphonate administration to humans, producing a mild imbalance between bone resorption and bone formation that results in an increase in bone mass (Liberman 1995; Saag et al. 1998). As a result, these studies suggest that the gelsolin-based signaling complex of the osteoclast podosome is an attractive target for pharmacologic regulation of bone resorption.
| Acknowledgments |
|---|
This work was supported by grant AR41677 (K.A. Hruska and M. Chellaiah) from the National Institutes of Health and the Monsanto/Washington University consortium.
Submitted: 21 September 1999
Revised: 21 December 1999
Accepted: 18 January 2000
Abbreviations used in this paper: Gsn–/–, Gsn+/+, gelsolin-null and wild-type mice, respectively; OP, osteopontin; PI3-K, phosphatidylinositol 3'-kinase; TRAP, tartrate-resistant acid phosphatase.
| References |
|---|
|
|
|---|
Andre E. Brink M. Gerisch G. Isenberg G. Noegel A. Schleicher M. Segali J.E. Wallraff E. A Dictyostelium mutant deficient in severin, an F-actin fragmenting protein, shows normal motility and chemotaxis, J. Cell Biol. 108, 1989 985–995.
Arora P.D. McCulloch C.A.G. Dependence of fibroblast migration on actin severing activity of gelsolin, J. Biol. Chem. 271, 1996 20516–20523.
Azuma T. Witke W. Stossel T.P. Hartwig J.H. Kwiatkowski D.J. Gelsolin is a downstream effector of rac for fibroblast motility, EMBO (Eur. Mol. Biol. Organ.) J. 17, 1998 1362–1370.[Medline]
Barkalow K. Hartwig J.H. Actin cytoskeleton. Setting the pace of cell movement, Curr. Biol. 5, 1995 1000–1002.[Medline]
Blair H.C. Teitelbaum S.L. Ghiselli R. Gluck S. Osteoclastic bone resorption by a polarized vacuolar proton pump, Nature. 245, 1989 855–857.
Boyce B.F. Yoneda T. Lowe C. Soriano P. Mundy G.R. Requirement of pp60c-src expression for osteoclasts to form ruffled borders and resorb bone in mice, J. Clin. Invest. 90, 1992 1622–1627.[Medline]
Buck C.A. Horwitz A.F. Integrin, a transmembrane glycoprotein complex mediating cell-substratum adhesion, J. Cell Sci. Suppl. 8, 1987 231–250.[Medline]
Chaponnier C. Gabbiani G. Gelsolin modulation in epithelial and stromal cells of mammary carcinoma, Am. J. Pathol. 134, 1989 597–603.[Abstract]
Chaponnier C. Kocher O. Gabbiani G. Modulation of gelsolin content in rat aortic smooth muscle cells during development, experimental intimal thickening and culture. An immunohistochemical and biochemical study, Eur. J. Biochem. 190, 1990 559–565.[Medline]
Chellaiah M. Hruska K.A. Osteopontin stimulates gelsolin associated phosphoinositide levels and PtdIns 3-hydroxyl kinase, Mol. Biol. Cell. 7, 1996 743–753.[Abstract]
Chellaiah M. Fitzgerald C. Filardo E.J. Cheresh D.A. Hruska K.A. Osteopontin activation of c-src in human melanoma cells requires the cytoplasmic domain of the integrin
v subunit, Endocrinology. 137, 1996 2432–2440.[Abstract]
Chellaiah M. Fitzgerald C. Alvarez U. Hruska K. C-src is required for stimulation of gelsolin associated PI3-K, J. Biol. Chem. 273, 1998 11908–11916.
Cunningham C.C. Stossel T.P. Kwiatkowiski D.J. Enhanced motility in NIH3T3 fibroblasts that overexpress gelsolin, Science. 251, 1991 1233–1236.
Ek-Rylander B. Flores M. Wendel M. Heinegard D. Andersson G. Dephosphorylation of osteopontin and bone sialoprotein by osteoclastic tartrate-resistant acid phosphatase, J. Biol. Chem. 269, 1994 14853–14856.
Gupta A. Edwards J.C. Hruska K.A. Cellular distribution and regulation of NHE-1 isoform of the Na-H exchanger in the avian osteoclast, Bone. 18, 1996 87–95.[Medline]
Hayman A.R. Jones S.J. Boyde A. Foster D. Colledge W.H. Carlton M.B. Evans M.J. Cox T.M. Mice lacking tartrate-resistant acid phosphatase (Acp 5) have disrupted endochondral ossification and mild osteopetrosis, Development. 122, 1996 3151–3162.[Abstract]
Hemken P. Guo X.-L. Wang A.-Q. Zhang K. Gluck S. Immunologic evidence that vacuolar H+ ATPases with heterogeneous forms of Mr = 31,000 subunit have different membrane distributions in mammalian kidney, J. Biol. Chem. 267, 1992 9948–9957.
Horton M.A. Townsend P. Nesbitt S. Cell surface attachment molecules in bone, Bilezikian J.P. Raisz L.G. Rodan G.A., Principles of Bone Biology, 1996 217–230 Academic Press San Diego, CA.
Janmey P.A. Stossel T.P. Modulation of gelsolin function by polyphosphoinositol(4,5)-bisphosphate, Nature. 325, 1987 362–364.[Medline]
Janmey P.A. Iida K. Yin H.L. Stossel T.P. Polyphosphoinositide micelles and polyphosphoinositide-containing vesicles dissociate endogenous gelsolin-actin complex and promote actin assembly from the fast growing end of actin filaments blocked by gelsolin, J. Biol. Chem. 262, 1987 12228–12236.
Jepsen K.J. Goldstein S.A. Kuhn J.L. Schaffler M.B. Bonadio J. Type-1 collagen mutation compromises the post-yield behavior of Mov13 long bone, J. Orthop. Res. 14, 1996 493–499.[Medline]
Jilka R.L. Weinstein R.S. Takahashi K. Parfitt A.M. Manolagas S.C. Linkage of decreased bone mass with impaired osteoblastogenesis in a murine model of accelerated senescence, J. Clin. Invest. 97, 1996 1732–1740.[Medline]
Kanehisa J. Heersche J.N.M. Osteoclastic bone resorptionin vitro analysis of the rate of resorption and migration of individual osteoclasts, Bone. 9, 1988 73–79.[Medline]
Kanehisa J. Yamanaka T. Doi S. Turksen K. Heersche J.N.M. Aubin J.E. Takeuchi H. A band of F-actin containing podosomes is involved in bone resorption by osteoclasts, Bone. 11, 1990 287–293.[Medline]
Kwiatkowski D.J. Predominant induction of gelsolin and actin-binding protein during myeloid differentiation, J. Biol. Chem. 263, 1988 13857–13862.
Kwiatkowski D.J. Functions of gelsolinmotility, signaling, apoptosis, cancer, Curr. Opin. Cell Biol. 11, 1999 103–108.[Medline]
Lakkakorpi P.T. Vaananen H.K. Kinetics of the osteoclast cytoskeleton during the resorption cycle in vitro, J. Bone Miner. Res. 6, 1991 817–826.[Medline]
Lakkakorpi P.T. Helfrich M.H. Horton M.A. Vaananen H.K. Spatial organization of microfilaments and vitronectin receptor,
vβ3, in osteoclasts, J. Cell Sci. 104, 1993 663–670.[Abstract]
Lakkakorpi P.T. Wesolowski G. Limolo L. Rodan G.A. Rodan S.B. Phosphatidylinositol 3-kinase association with the osteoclast cytoskeleton and its involvement in osteoclast attachment and spreading, Exp. Cell Res. 237, 1997 296–306.[Medline]
Lauffenburger D.A. Horwitz A.F. Cell migrationa physically integrated molecular process, Cell. 84, 1996 359–369.[Medline]
Liberman U.A. Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis, N. Engl. J. Med. 333, 1995 1437–1443.
Lu M. Witke W. Kwiatkowski D.J. Kosik K.S. Delayed retraction of filopodia in gelsolin null mice, J. Cell Biol. 138, 1997 1279–1287.
Machesky L.M. Insall R.H. Signaling to actin dynamics, J. Cell Biol. 146, 1999 267–272.
Maejima-Ikeda A. Aoki M. Tsuritani K. Kamioka K. Hiura K. Miyoshi T. Hara H. Takano-Yamamoto T. Kumegawa M. Chick osteocyte-derived protein inhibits osteoclastic bone resorption, Biochem. J. 322, 1997 245–250.[Medline]
Marchisio P.C. Naldini L. Cirillo D. Primavera M.V. Teti A. Zambonin-Zallone A. Cell-substratum interactions of cultured avian osteoclasts is mediated by specific adhesion structures, J. Cell Biol. 99, 1984 1696–1705.
Marchisio P.C. Cirillo D. Teti A. Zambonin Zallone A. Tarone G. Rous sarcoma virus-transformed fibroblasts and cells of monocytic origin display a peculiar dot-like organization of cytoskeletal proteins involved in microfilament-membrane interaction, Exp. Cell Res. 169, 1987 202–214.[Medline]
Marks S.C. Jr. Osteoclast biologylessons from mammalian mutations, Am. J. Med. Genet. 34, 1989 43–54.[Medline]
Nakamura I. Sasaki T. Tanaka S. Takahashi N. Jimi E. Kurokawa T. Kita Y. Ihara S. Suda T. Fukui Y. Phosphatidylinositol-3 kinase is involved in ruffled border formation in osteoclasts, J. Cell Physiol. 172, 1997 230–239.[Medline]
Parfitt A.M. Drezner M.K. Glorieux F.H. Kanis J.A. Malluche H. Meunier P.J. Ott S.M. Recker R.R. Bone histomorphometrystandardization of nomenclature, symbols, and units, J. Bone Miner. Res. 2, 1987 595–610.[Medline]
Rodriguez Fernandez J.L. Geiger B. Salomon D. Ben-Ze'ev A. Overexpression of vinculin suppresses cell motility in BALB/c 3T3 cells, Cell Motil. Cytoskelet. 22, 1992 127–134.[Medline]
Rodriguez Fernandez J.L. Geiger B. Salomon D. Ben-Ze'ev A. Suppression of vinculin expression by antisense transfection confers changes in cell morphology, motility, and anchorage-dependent growth of 3T3 cells, J. Cell Biol. 122, 1993 1285–1294.
Saag K.G. Emkey R. Schnitzer T.J. Brown J.P. Hawkins F. Goemaere S. Thamsborg G. Liberman U.A. Delmas P.D. Malice M.-P. Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis, N. Engl. J. Med. 339, 1998 292–299.
Schafer D.A. Cooper J.A. Control of actin assembly at filament ends, Annu. Rev. Cell Dev. Biol. 11, 1995 497–518.[Medline]
Schwartzberg P.L. Xing L. Hoffmann O. Lowell C.A. Garrett L. Boyce B.F. Varmus H.E. Rescue of osteoclast function by transgenic expression of kinase-deficient Src in Src–/– mutant mice, Genes Dev. 11, 1997 2835–2844.
Senger D.R. Ledbetter S.R. Claffey K.P. Papadopoulos-Sergiou A. Perruzzi C.A. Detmar M. Stimulation of endothelial cell migration by vascular permeability factor/vascular endothelial growth factor through cooperative mechanisms involving the
vβ3 integrin, osteopontin, and thrombin, Am. J. Pathol. 149, 1996 293–305.[Abstract]
Shioi A. Ross F.P. Teitelbaum S.L. Enrichment of generated murine osteoclasts, Calcif. Tissue Int. 55, 1994 387–394.[Medline]
Steimle P.A. Hoffert J.D. Adey N.B. Craig S.W. Polyphosphoinositides inhibit the interaction of vinculin with actin filaments, J. Biol. Chem. 274, 1999 18414–18420.
Stossel T.P. From signal to pseudopod. How cells control cytoplasmic actin assembly, J. Biol. Chem. 264, 1989 18261–18264.
Stossel T.P. Chaponnier C. Ezzell R.M. Hartwig J.H. Janmey P.A. Kwiatkowski D.J. Lind S.E. Smith D.B. Southwick F.S. Yin H.L. Zaner K.S. Nonmuscle actin-binding proteins, Annu. Rev. Cell Biol. 1, 1985 353–402.
Takahashi S. Goldring S. Katz M. Hilsenbneck S. Williams R. Roodman G.D. Down regulation of calcitonin receptor mRNA expression by calcitonin during human osteoclast-like cell differentiation, J. Clin. Invest. 95, 1995 167–171.[Medline]
Taylor M.L. Boyde A. Jones S.J. The effect of fluoride on the patterns of adherence of osteoclasts cultured on and resorbing dentinea 3-D assessment of vinculin-labelled cells using confocal optical microscopy, Anat. Embryol. 180, 1989 427–435.[Medline]
Teti A. Marchisio P.C. Zambonin-Zallone A. Clear zone in osteoclast functionrole of podosomes in regulation of bone-resorbing activity, Am. J. Physiol. 261, 1991 C1–C7.[Medline]
Turksen K. Kanehisa J. Opas M. Heersche J.N. Aubin J.E. Adhesion patterns and cytoskeleton of rabbit osteoclasts on bone slices and glass, J. Bone Miner. Res. 3, 1988 389–400.[Medline]
Vandekerckhove J. Vancompernolle K. Gelsolin modulation in epithelial and stromal cells of mammary carcinoma, Curr. Opin. Cell Biol. 4, 1992 36–42.[Medline]
Weeds A. Maciver S. F-actin capping proteins, Curr. Opin. Cell Biol. 5, 1993 63–69.[Medline]
Weinstein R.S. Jilka R.L. Parfitt A.M. Manolagas S.C. The effects of androgen deficiency on murine bone remodeling and bone mineral density are mediated via cells of the osteoblastic lineage, Endocrinology. 138, 1997 4013–4021.
Wesolowski G. Duong L.T. Lakkakorpi T. Nagy R.M. Tezuka K.I. Tanaka H. Rodan G.A. Rodan S.B. Isolation and characterization of highly enriched perfusion mouse osteoclastic cells, Exp. Cell Res. 219, 1995 679–686.[Medline]
Witke W. Sharpe A. Hartwig J. Azuma T. Stossel T. Kwiatkowski D. Hemostatic, inflammatory, and fibroblast responses are blunted in mice lacking gelsolin, Cell. 81, 1995 41–51.[Medline]
Wu H. Kanner S.B. Reynolds A.B. Vines R.R. Parson J.T. Identification and characterization of a novel cytoskeleton associated pp60c-src substrate, Mol. Cell. Biol. 11, 1991 5113–5124.
Xu W. Coll J.-L. Adamson E.D. Rescue of the mutant phenotype by reexpression of full-length vinculin in null F9 cells; effects on cell locomotion by domain deleted vinculin, J. Cell Sci. 111, 1998 1535–1544.[Abstract]
Yin H.L. Gelsolincalcium and phosphoinositide regulated actin modulating protein, Bioessays. 7, 1987 176–179.[Medline]
Yin H.L. Calcium and polyphosphoinositide regulation of actin network structure by gelsolin, Adv. Exp. Med. Biol. 255, 1989 315–323.[Medline]
Zambonin-Zallone A. Teti A. Primavera M.V. Naldini L. Marchisio P.C. Osteoclasts and monocytes have similar cytoskeletal structures and adhesion property in vitro, J. Anat. 137, 1983 57–70.[Medline]
Zambonin-Zallone A. Teti A. Grano M. Rubinacci A. Abbadini M. Gaboli M. Marchisio C. Immunocytochemical distribution of extracellular matrix receptors in human osteoclastsa beta3 integrin is co-localized with vinculin and talin in the podosomes of osteoclastoma giant cells, Exp. Cell Res. 182, 1989 645–652.[Medline]
Zhang D. Udagawa N. Nakamura I. Murakami H. Saito S. Yamasaki K. Shibasaki Y. Morij N. Narumiya S. Takahashi N. Suda T. The small GTP-binding protein, rho p21, is involved in bone resorption by regulating cytoskeletal organization in osteoclasts, J. Cell Sci. 108, 1995 2285–2292.[Abstract]
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|